Invesco »

Nektar Therapeutics shares owned by Invesco

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Invesco

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 227k 61.00
2025-06-30 $448k 32k 14.00

More positions owned by Invesco

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Netflix (NFLX)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
Cisco Systems (CSCO)

View all positions for Invesco

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics